# Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis

> **NCT04072822** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 147 (actual)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** Anakinra and Zinc
- **DRUG:** Prednisone
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04072822
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-10
- **Primary completion:** 2022-05-24
- **Final completion:** 2022-08-12
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04072822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04072822, "Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04072822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*